Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LENDEXAL: Lenalidomide, Cyclophosphamide, and Dexamethasone for Newly Diagnosed AL Amyloidosis
NCT01194791Phase 2Completed
- Sponsor
- Fundación PETHEMA
- Start
- Oct 2010
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in primary systemic amyloidosis, sponsored by Fundación PETHEMA. Started Oct 2010; status: completed.
02
Drugs
lenalidomide
03
Conditions
primary systemic amyloidosis
Beyond the preview
Go deeper on NCT01194791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01194791.